signs

Pendopharm, a division of Pharmascience, said it has signed an exclusive distribution agreement with Denmark-based biopharmaceutical company Ascendis Pharma A/S (ASND). Under the terms of the agreement, Pendopharm is responsible for regulatory approval and commercialization of Ascendis’ hypoparathyroidism treatment TransCon PTH in Canada. Financial terms of the agreement are not disclosed.Continue Reading

Ocean Power Technologies (NYSE:OPTT) on Thursday announced the signing of an Original Equipment Manufacture agreement with Teledyne Marine, a division of Teledyne Technologies (NYSE:TDY), a supplier in the maritime technology inclusive of connectors, instruments, and vehicles. “This strategic partnership aims to enhance OPT’s product offerings and drive innovation within the industryContinue Reading